Although it has been suggested that the unbound, free, (B f ) rather than total (B T ) bilirubin level correlates with cell toxicity, direct experimental evidence supporting this conclusion is limited. In addition, previous studies never included a direct measurement of B f , using newer, accurate methods. To test "the free bilirubin hypothesis", in vitro cytotoxicity was assessed in four cell lines exposed to different B f concentrations obtained by varying B T /Albumin ratio, using serum albumins with different binding affinities, and/or displacing unconjugated bilirubin (UCB) from albumin with a sulphonamide. B f was assessed by the modified, minimally diluted peroxidase method. Cytotoxicity varied among cell lines but was invariably related to B f and not B T . Light exposure decreased toxicity parallel to a decrease in B f . In the absence of albumin, no cytotoxicity was found at a B f of 150 nM whereas in the presence of albumin a similar B f resulted in a 40% reduction of viability indicating the importance of total cellular uptake of UCB in eliciting toxic effect. In the presence of albumin-bound UCB, bilirubin-induced cytotoxicity in a given cell line is accurately predicted by B f irrespective of the source and concentration of albumin, or total bilirubin level. (Pediatr Res 62: 576-580, 2007) P lasma levels of unconjugated bilirubin (UCB) are elevated in almost all newborn infants. In some infants with markedly elevated plasma UCB levels, bilirubin causes neurotoxicity, sometimes resulting in permanent neurologic dysfunction (1). Management guidelines for jaundiced term and near-term infants, published by the American Academy of Pediatrics (AAP), are based on the premise that total serum bilirubin concentration (B T ) is the best available predictor of risk for bilirubin-induced neurologic damage (BIND) (2). Clinical evidence has indicated, however, that B T , beyond a threshold value of 20 mg/dL, is a poor discriminator of individual risk for BIND (3,4). Since over 99.9% of total plasma UCB (B T ) is bound to albumin or apolipoprotein D (5) and only unbound bilirubin can enter the brain across an intact blood-brain barrier, the level of unbound "free" bilirubin (B f ) should theoretically provide a more accurate indication of the risk of kernicterus.
P lasma levels of unconjugated bilirubin (UCB) are elevated in almost all newborn infants. In some infants with markedly elevated plasma UCB levels, bilirubin causes neurotoxicity, sometimes resulting in permanent neurologic dysfunction (1) . Management guidelines for jaundiced term and near-term infants, published by the American Academy of Pediatrics (AAP), are based on the premise that total serum bilirubin concentration (B T ) is the best available predictor of risk for bilirubin-induced neurologic damage (BIND) (2) . Clinical evidence has indicated, however, that B T , beyond a threshold value of 20 mg/dL, is a poor discriminator of individual risk for BIND (3, 4) . Since over 99.9% of total plasma UCB (B T ) is bound to albumin or apolipoprotein D (5) and only unbound bilirubin can enter the brain across an intact blood-brain barrier, the level of unbound "free" bilirubin (B f ) should theoretically provide a more accurate indication of the risk of kernicterus.
Published studies of UCB toxicity in cell cultures, conducted with different types of albumin at varied molar ratios of bilirubin/albumin (6 -9) reported an increase in cell damage depending on B T . The hypothesis that cell injury is correlated better with B f was first suggested by Nelson et al. (10) in an in vitro study. Moreover, Ostrow et al. (11) reported a meta analysis of in vitro studies that suggested cytotoxicity was better correlated with B f (11) . This conclusion was however based on B f calculations using published binding constants, rather than direct measurement in the culture medium, and was thus limited by unknown variations in binding associated with differences in the composition of the incubation media.
In jaundiced newborns, plasma B f levels at any given B T or B T /albumin ratio can vary widely due to varying concentrations of albumin and apolipoprotein D, differences in the binding affinity, and/or the presence of inhibitors of binding (12) . B f , therefore, cannot be accurately predicted from the concentrations of B T and albumin in plasma or culture medium, and must be measured directly. A modified, enzymatic peroxidase method has been developed to measure B f in plasma (12) and tissue culture media (13) , with minimal dilution of the sample. This is important, since the binding affinity for UCB decreases markedly with increasing albumin concentration (12, 13) . This assay is based on the observation that, in the presence of peroxidase and peroxide, unbound bilirubin is oxidized to colorless compounds, whereas proteinbound bilirubin is protected from oxidation (14) .
The present study, for the first time, directly tests the hypothesis that B f , measured with the peroxidase method, rather than B T predicts the toxicity of UCB in several cell lines under a wide variety of incubation conditions, using 3(4,5-dimethiltiazolil-2)-2,5 diphenyl tetrazolium (MTT) reduction to assess cell viability. Cell culture. A human neuroblastoma cell line (SHSY5Y) was grown under 5% CO 2 in F-12/EMEM (1:1) supplemented with penicillin, streptomycin, GlutaMAX™, MEM and 15% FCS. HeLa, primary mouse embryo fibroblast (MEF) and Striatal precursor 2a1 cell lines (15) were grown in DMEMHG with penicillin, streptomycin and 10% FCS at 37°C, except for 2a1 cells that were incubated at 33°C under 5% CO 2 . SHSY5Y and Striatal precursor 2a1 cell lines were kindly provided by Dr S. Gustincich (SISSA, Trieste, Italy). MEF were prepared as described by Hertzog (16) . The animal protocol was approved by the Animal Care and Use Committee of the University of Trieste.
MATERIALS AND METHODS

Materials
Preparation of bilirubin/albumin systems. UCB was purified by the method of Ostrow and Mukerjee (17), divided into 200 or 400 g aliquots, and stored at Ϫ20°C until used. Just before use, an aliquot was dissolved in 66 or 133 L DMSO, yielding a stock solution containing 5 mM UCB, which was added to the albumin-containing culture medium to attain the desired B T with a final DMSO concentration that did not exceed 1% (vol/vol).
Cell viability by MTT reduction. Cells were plated in 24 multiwell plates, achieving 70 -80% confluence by the following day. The growing medium was then discarded, cells were washed with PBS at 37°C and exposed to UCB dissolved in the respective culture medium containing either FCS 15% (54 M albumin), 30 M or 60 M HSA, or 30 M BSA. Control cells were incubated in the same medium to which had been added the same volume of DMSO as the added stock UCB solution. After incubation with the UCB, the medium containing UCB was removed and replaced with culture medium containing MTT 0.5 mg/mL (18) . After incubating the cells with MTT for 2 h at 37°C, the medium was discarded and MTT formazan crystals dissolved by adding 0.4 mL isopropanol/HCl 0.04 M and gentle shaking for 2 h at 37°C. After centrifugation, absorbance values at 570 nm were determined in a LD 400C Luminescence Detector, Beckman Coulter, Milan, Italy. Results were expressed as percentage of MTT reduction by cells not exposed to UCB, which was considered as 100% viability.
B f measurements. The unbound bilirubin (B f ) concentrations were determined using a modification of the horseradish peroxidase assay (12) as described by Roca-Burgos et al. (13) . The method involves minimal dilution of the sample, minimizing the effect of dilution of the albumin concentration on binding affinity (19) .
Effect of different albumin preparations on B f levels and time course of toxicity. The relationship of B f , B T , and different albumin preparations on binding and toxicity were examined by incubating cells in media containing 30 or 60 M HSA, 30 M BSA or 10% FCS and varying bilirubin/ albumin molar ratios to yield three ranges of B f concentrations (10 -20, 40 -50, and 80 -90 nM). Cell viability was ascertained following a 2h exposure to bilirubin. This time interval was based on a time course curve made for each cell line.
We compared the susceptibility of four cell lines to bilirubin toxicity: HeLa cells (20) and mouse embryo fibroblasts (21), previously used for bilirubin studies in our laboratory, and two neuronal cell lines, SHSY5Y neuroblastoma cells and striatal precursor 2a1 cells.
Effect of sulfadimethoxine on B f and cell viability. B f was measured under the optimal growth conditions (15% FCS) for SHSY5Y, with or without 250 M sulfadimethoxine, a strong binding competitor for UCB (22) . B T ranged from 3 to 32 M with total BSA concentration of 54 M. Similar B f in the presence and absence of sulfadimethoxine were established by using much lower B T concentrations in the presence of sulfadimethoxine. Control systems contained 250 M sulfadimethoxine and the same volume of DMSO, but no UCB. Cells were incubated for 2 h and MTT assay then performed.
Effect of light exposure on B f and toxicity. The effect of light (1000 lux) on B f was evaluated using 15% FCS and 32 M UCB in F12/EMEM medium. The solution flask was placed 10 cm below a GE polylux XL F36W/840 fluorescent lamp (General Electric Company, UK) for 60 min, and B f measured after warming to 37°C. SHSY5Y cells were then incubated for 2 h in medium that had or had not been exposed to light and viability was assessed by MTT assay.
Statistical analysis. Results are expressed as mean Ϯ SD of three experiments for each experimental condition. Statistical analysis was performed by ANOVA with Tukey test, using GraphPad InStat 3 software (San Diego, CA). Differences among the conditions were considered significant at p Ͻ 0.05.
RESULTS
Effect of different binders on B f levels. With all 3 types of albumin, B f increased with increasing B T (Fig. 1) . At a given B T , 30 M BSA and 10% (vol/vol) FCS yielded comparable B f values. These were roughly double the B f obtained using the same concentration of HSA when B T was lower than 15 M, consistent with the weaker binding affinity of BSA (13) .
Effect of B f on cell viability in different cell lines. Figure 2 shows the changes in cell viability when the 4 cell lines were exposed to a B f of 10 -20, 40 -50 and 80 -90 nM for 2 h. A constant B f with varying B T was obtained by using albumin preparations with different binding characteristics, as shown in Fig. 1 . Irrespective of B T , similar toxicity was observed at similar B f obtained by varying the type of albumin and the UCB/albumin ratios, or displacing UCB with sulfadimethoxine (Fig. 3) . 
FREE BILIRUBIN PREDICTS CYTOTOXICITY
Although the susceptibility to damage differed among the 4 cell lines, their viability after two hours of incubation with UCB generally decreased as B f increased (Fig. 2) . SHSY5Y cells were most sensitive to UCB with about a 20% loss of viability at B f ϭ 40 -50 and 30% loss at B f ϭ 80 -90 nM (p Ͻ 0.05 for each). HeLa cells were likewise significantly affected at these concentrations, albeit less severely. In contrast, 2a1 cells showed a modest decrease in viability only at a B f ϭ 80 -90 nM (p Ͻ 0.05) while MEF cells showed a trend toward decreased viability that did not achieve statistical significance. Similar results were observed after 1 h exposure to UCB: viability of SHSY5Y cells was already significantly impaired at B f ϭ 40 nM, whereas HeLa, 2a1 and MEF cells showed unimpaired survival even at B f ϭ 80 -90 nM (data not shown). Longer exposure (6 h) to a Bf ϭ 80 -90 nM resulted in a further increase in cytotoxicity in SHSY5Y cells (40 Ϯ 3% decrease in viability) and the appearance of a cytotoxic effect in the other cell lines (20 Ϯ 5 for HeLa, 15 Ϯ 4% for 2a1 and 16 Ϯ 3 for MEF).
Effect of sulfadimethoxine on B f and on viability of SHSY5Y cells. As shown in Fig. 3 , B f increased about 5 fold and 3 fold in the presence of sulfadimethoxine, when the bilirubin/FCS molar ratios were 0.11 and 0.22 respectively, confirming the ability of the drug to displace UCB from albumin. Sulfadimethoxine in the absence of UCB had no effect on cell viability (100 Ϯ 9.1 control versus. 94.4 Ϯ 12.4 treated cells, NS). Loss of cell viability was comparable at any given B f level, irrespective of B T (low in the presence of sulfadimethoxine) or B T /albumin molar ratio.
Effect of B f on cell viability without albumin. We exposed SHSY5Y cells for 2 h to B T ranging from 10 to 1000 nM, without albumin. Thus, all UCB in the medium is initially "free" (B f ϭ B T ). Cell viability remained unchanged up to B f ϭ 500 nM (Fig. 4) . In contrast, cells incubated in the presence of 15% vol/vol FCS and increasing concentrations of 
DISCUSSION
In this study we demonstrated variable sensitivity of four different cell lines to bilirubin toxicity. Loss of viability was dependent on the free bilirubin level (B f ) but not the total bilirubin concentration (B T ), whether or not the B f is varied by using preparations of albumin with different binding affinities, or by displacement of UCB from albumin by sulfadimethoxine. The results obtained with sulfadimethoxine confirm the observation that viability of cultured 8402 human cells correlated (r 2 ϭ 0.94) with the square root of B f level, with or without sulfisoxazole (24) . SHSY5Y cells, a neuronal model for studies of Alzheimer's disease (25) , are more sensitive to UCB cyotoxicity than the 3 nonneuronal cell lines tested. The response of SHSY5Y cells to bilirubin is similar to other neuronal or astrocytic cell lines reported in the literature (11). 
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Interestingly, this greater susceptibility of SHSY5Y cells to UCB toxicity is manifested both at lower B f and at shorter incubation times compared with the other three cell lines tested. Although the molecular pathogenesis of bilirubininduced neuronal cell injury is not completely understood, cell damage at any given B f is affected by a variety of mechanisms (26) including export of UCB by ABC transporters, binding of UCB by cytosolic proteins, cellular oxidation and conjugation of UCB.
We observed a marked difference in dose-response when SHSY5Y cells were exposed to UCB in the absence of albumin. The B f required for a comparable decrease in viability was more than double that observed with albumin present. Nelson reported similar findings with L929 cells (10) . These results can be explained in part by self-aggregation of unbound UCB and by the reservoir function of the albuminbound UCB. The true determinant of UCB cytotoxicity is the intracellular content of UCB. In the absence of the reservoir of albumin-bound UCB, the small amount of unbound UCB in the extracellular fluid in our experimental system (150 pmol at a B f (ϭ B T ) of 150 nM) is quickly consumed, so that a sufficiently high toxic intracellular level of UCB is not reached. Unfortunately, due to extremely low concentration, it was impossible to measure the "equilibrium" extracellular B T in the absence of albumin, or to compare the intracellular UCB concentrations with and without albumin. With albumin present, UCB taken up from the extracellular pool of unbound UCB is instantaneously replaced by dissociation of bound UCB from the albumin, thus maintaining a constant B f . In the presence of 15% FCS, a B f of 150 nM requires a total bilirubin content of 20,000 pmol i.e., more than 130 times greater than that found at a comparable Bf in the absence of FCS. Binding to albumin also prevents the pigment from aggregating and precipitating and stabilizes the pigment against oxidation (27) . Collectively these data indicate that in addition to the B f , the total amount of UCB available for uptake is also important to predict cellular damage. In vivo, the presence of a large reservoir of albumin-bound UCB renders this consideration irrelevant.
Application of phototherapy to jaundiced infants produces photo-isomers and photo-oxidative derivatives of UCB. The water soluble photo-isomers are thought to be nontoxic, although confirming experimental evidence is lacking, and they cannot be discriminated from native UCB (bilirubin IX␣ z,z ) by usual assays for B T . There is evidence that these isomers bind less avidly to albumin (28) , and concern has been raised that they will be oxidized faster than bilirubin IX␣ z,z , and yield misleading values of B f (29, 30) . Our data support previous observations that photo-products do not significantly alter the measurement of B f (31, 32) , either by displacing native UCB from the binding site and/or by having a lower binding affinity to the albumin or the peroxidase enzyme. Regardless of mechanism, the predictable relationship between measured B f and toxicity in medium exposed to intense light supports the validity of the peroxidase assay in evaluating risk for bilirubin toxicity when photo-isomers are present.
The presence of serum or albumin in culture media is often necessary for optimal cell growth. The use of BSA or FCS rather than HSA in studies of UCB cytotoxicity in vitro is supported by several reasons among which the most relevant are: 1) BSA is much less expensive than HSA; and 2) BSA has a lower affinity constant for UCB, requiring a much lower B T to achieve any given B f level (13) . Using the peroxidase method (12) , B f can be easily measured without dilution of culture medium in any study where BSA or FCS is used as a UCB reservoir (13) . Measurement of B f in all in vitro experiments would greatly facilitate interpretation and comparison of dose-response studies conducted in different laboratories under different conditions. This study supports the "free bilirubin theory" which hypothesizes that bilirubin toxicity occurs when unbound bilirubin enters the brain and binds to intracellular structures (1) . A recent outcome study of newborns exposed to marked hyperbilirubinemia (4) emphasizes the limitation of B T as a predictor of neurologic outcome. Verification of B f as the critical determinant of toxicity in vitro reinforces the proposal to assess the risk for kernicterus by measuring B f in hyperbilirubinemic newborn plasma (3), rather than depending solely on B T , as currently recommended by the American Academy of Pediatrics (2) .
